PINLYP-mediated phospholipid metabolism reprogramming contributes to chronic herpesvirus infection
PLOS Pathogens · 2025
DOI: 10.1371/journal.ppat.1013146 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2025. Verfasst von Zhangmengxue Lei und 14 weiteren Autor:innen. Beteiligte Einrichtung: University of Chinese Academy of Sciences, Shanghai Institute of Immunity and Infection, Chinese Academy of Sciences, Shanghai, China. Hauptthemen laut MEDLINE: Phospholipids, Herpesvirus 8, Human, Herpesviridae Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Natural Science Foundation of China, Shanghai Municipal Science and Technology Major Project.
Abstract (Originalsprache)
Many viruses alter the phospholipid metabolism to benefit their own life cycles. It is unclear whether the host or the virus is driving phospholipid metabolism reprogramming, and how virus infections are affected by the metabolic status. Here we report that phospholipase A2 inhibitor and LY6/PLAUR domain-containing protein (PINLYP) inhibits Kaposi’s sarcoma-associated herpesvirus (KSHV) lytic reactivation by remodeling phospholipid metabolism and especially triacylglycerol (TAG) biosynthesis. PINLYP deficiency led to increased phospholipase cPLA2α activity, cPLA2α-mediated AKT phosphorylation, and KSHV lytic reactivation. Analyses of RNA-seq and lipidomics reveal that PINLYP regulates long-chain fatty acid CoA ligase ACSL5 expression and TAG production. The inhibition of ACSL5 activity or TAG biosynthesis suppresses AKT phosphorylation and KSHV lytic reactivation, restoring the phenotype of PINLYP deficiency. This finding underscores the pivotal role of PINLYP in remodeling phospholipid metabolism and promoting viral latency, which sheds new light on how phospholipid metabolism is regulated by herpesvirus and provides a potential target for controlling chronic herpesvirus infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University of Chinese Academy of Sciences, Shanghai Institute of Immunity and Infection, Chinese Academy of Sciences, Shanghai, China.
- State Key Laboratory of Virology, Modern Virology Research Center, College of Life Sciences, Wuhan University, Wuhan, China.
ORCID-Profile: Xiaozhen Liang
Förderung
- National Key Research and Development Program of China
- Natural Science Foundation of China
- Shanghai Municipal Science and Technology Major Project
Zitieren
APA
Lei, Z., Wei, W., Wang, M., Xu, Y., Bai, L., Gao, Y., Jiang, C., Li, F., Tian, N., Kuang, L., Zhu, R., Pang, G., Lan, K., Feng, S., & Liang, X. (2025). PINLYP-mediated phospholipid metabolism reprogramming contributes to chronic herpesvirus infection. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1013146
Vancouver
Lei Z, Wei W, Wang M, Xu Y, Bai L, Gao Y, et al. PINLYP-mediated phospholipid metabolism reprogramming contributes to chronic herpesvirus infection. PLOS Pathogens. 2025. doi:10.1371/journal.ppat.1013146
BibTeX
@article{Lei2025,
author = {Lei, Zhangmengxue and Wei, Wendi and Wang, Mingyu and Xu, Yun and Bai, Lei and Gao, Ying and Jiang, Congwei and Li, Fangxia and Tian, Na and Kuang, Linlin and Zhu, Ruiliang and Pang, Gang and Lan, Ke and Feng, Suihan and Liang, Xiaozhen},
title = {PINLYP-mediated phospholipid metabolism reprogramming contributes to chronic herpesvirus infection},
journal = {PLOS Pathogens},
year = {2025},
doi = {10.1371/journal.ppat.1013146}
}
EUVIMED